Molyneux PD[au] - Search Results

Year	Number of Results
1989	1
1998	5
1999	7
2000	5
2001	2
2002	1
2009	1
2010	1
2011	1
2021	2
2022	1
2023	0

1

Phillips W, Price J, Molyneux PD, Deeley Q. Phillips W, et al. Among authors: molyneux pd. Pract Neurol. 2022 Feb;22(1):42-47. doi: 10.1136/practneurol-2020-002839. Epub 2021 Aug 13. Pract Neurol. 2022. PMID: 34389642

2

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

Molyneux PD, Filippi M, Barkhof F, Gasperini C, Yousry TA, Truyen L, Lai HM, Rocca MA, Moseley IF, Miller DH. Molyneux PD, et al. Ann Neurol. 1998 Mar;43(3):332-9. doi: 10.1002/ana.410430311. Ann Neurol. 1998. PMID: 9506550 Review.

3

Migraine, an open and shut case?

Molyneux PD, Jordan K. Molyneux PD, et al. Pract Neurol. 2010 Jun;10(3):172-5. doi: 10.1136/jnnp.2010.212704. Pract Neurol. 2010. PMID: 20498194 No abstract available.

4

Decoding neuronal ensembles in the human hippocampus.

Hassabis D, Chu C, Rees G, Weiskopf N, Molyneux PD, Maguire EA. Hassabis D, et al. Among authors: molyneux pd. Curr Biol. 2009 Apr 14;19(7):546-54. doi: 10.1016/j.cub.2009.02.033. Epub 2009 Mar 12. Curr Biol. 2009. PMID: 19285400 Free PMC article.

5

Beyond PPE: a mixed qualitative-quantitative study capturing the wider issues affecting doctors' well-being during the COVID-19 pandemic.

Cubitt LJ, Im YR, Scott CJ, Jeynes LC, Molyneux PD. Cubitt LJ, et al. Among authors: molyneux pd. BMJ Open. 2021 Mar 22;11(3):e050223. doi: 10.1136/bmjopen-2021-050223. BMJ Open. 2021. PMID: 33753449 Free PMC article.

6

The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS.

Brex PA, Molyneux PD, Smiddy P, Barkhof F, Filippi M, Yousry TA, Hahn D, Rolland Y, Salonen O, Pozzilli C, Polman CH, Thompson AJ, Kappos L, Miller DH; European Study Group on Interferon beta-1b in Secondary Progressive MS. Brex PA, et al. Among authors: molyneux pd. Neurology. 2001 Dec 26;57(12):2185-90. doi: 10.1212/wnl.57.12.2185. Neurology. 2001. PMID: 11756595 Clinical Trial.

7

Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations.

Kelly JA, Molyneux PD, Smith SA, Smith SE. Kelly JA, et al. Among authors: molyneux pd. Br J Ophthalmol. 1989 May;73(5):360-2. doi: 10.1136/bjo.73.5.360. Br J Ophthalmol. 1989. PMID: 2730857 Free PMC article. Clinical Trial.

8

Tricyclic antidepressants reduce frequency of tension-type and migraine headaches compared with placebo, and intensity of headaches compared with SSRIs, but cause greater adverse effects.

Molyneux PD. Molyneux PD. Evid Based Med. 2011 Jun;16(3):75-6. doi: 10.1136/ebm1176. Epub 2011 Jan 19. Evid Based Med. 2011. PMID: 21252162 No abstract available.

9

Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.

Brex PA, Gomez-Anson B, Parker GJ, Molyneux PD, Miszkiel KA, Barker GJ, MacManus DG, Davie CA, Plant GT, Miller DH. Brex PA, et al. Among authors: molyneux pd. J Neurol Sci. 1999 Jun 15;166(1):16-22. doi: 10.1016/s0022-510x(99)00105-7. J Neurol Sci. 1999. PMID: 10465494

10

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

Paolillo A, Coles AJ, Molyneux PD, Gawne-Cain M, MacManus D, Barker GJ, Compston DA, Miller DH. Paolillo A, et al. Among authors: molyneux pd. Neurology. 1999 Sep 11;53(4):751-7. doi: 10.1212/wnl.53.4.751. Neurology. 1999. PMID: 10489036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results